Publications by authors named "Magda Marcatti"

Claim this Profile
P
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab-, Elotuzumab-, and Carfilzomib-Based Triplet Regimens: A Multicenter Real-World Analysis of 635 Patients.
Fortunato Morabito, Enrica Antonia Martino, Monica Galli, Massimo Offidani, Renato Zambello, Magda Marcatti

Eur J Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation.
Francesco Autore, Daniele Mannina, Federica Lessi, Eugenio Galli, Stefania Oliva, Magda Marcatti

Hematol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions.
Valeria Ferla, Francesca Farina, Tommaso Perini, Magda Marcatti, Fabio Ciceri

Pharmaceuticals (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients.
Simona Piemontese, Maria Teresa Lupo Stanghellini, Federica Sora, Simona Sica, Jacopo Peccatori, Magda Marcatti

Bone Marrow Transplant· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.
Anna Furlan, Michele Cea, Laura Pavan, Monica Galli, Cristina Clissa, Magda Marcatti

Cancer Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome?
Francesco Autore, Stefania Bramanti, Federica Lessi, Idanna Innocenti, Eugenio Galli, Magda Marcatti

Haematologica· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher cyclophosphamide dose grants optimal stem cell collection after daratumumab-based induction in multiple myeloma.
Carmine Liberatore, Tommaso Perini, Cecilia Passeri, Valeria Ferla, Francesca Fioritoni, Magda Marcatti

Haematologica· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination treatment of dupilumab with bortezomib in a patient with IgG kappa gammopathy of renal significance, uremic pruritus and chronic lichenoid dermatitis.
Paolino Giovanni, Matteo Riccardo Di Nicola, Magda Marcatti, Nathalie Rizzo, Vittoria Bianchi

Acta Biomed· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrabone Transplantation of a Single Unwashed Umbilical Cord Blood Unit with Antithymocyte Globulin-Free and Sirolimus-Based Graft-versus-Host Disease Prophylaxis: Fast Immune Reconstitution and Long-Term Disease Control in Patients with High-Risk Diseases.
Fabio Giglio, Elisabetta Xue, Angelica Barone, Francesca Lorentino, Raffaella Greco, Magda Marcatti

Transplant Cell Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation.
Enrique M Ocio, Aurore Perrot, Pierre Bories, Jesus F San-Miguel, Igor W Blau, Magda Marcatti

Leukemia· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis.
Silvia Mangiacavalli, Claudio Salvatore Cartia, Monica Galli, Sara Pezzatti, Angelo Belotti, Magda Marcatti

Haematologica· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monkeypox infection in a hemopoietic stem cell and heart transplant recipient.
Angelo Roberto Raccagni, Davide Mileto, Caterina Candela, Elena Bruzzesi, Fiorenza Bracchitta, Magda Marcatti

J Med Virol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy.
Valeria Ferla, Elena Antonini, Tommaso Perini, Francesca Farina, Serena Masottini, Magda Marcatti

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation.
Fabio Giglio, Elisabetta Xue, Raffaella Greco, Lorenzo Lazzari, Daniela Teresa Clerici, Magda Marcatti

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation.
Francesca Lorentino, Elisabetta Xue, Sara Mastaglio, Fabio Giglio, Daniela Clerici, Magda Marcatti

Blood Adv· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience.
Simona Piemontese, Lorenzo Lazzari, Annalisa Ruggeri, Magda Marcatti, Maria Teresa Lupo Stanghellini

Bone Marrow Transplant· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study.
Elisabetta Xue, Francesca Lorentino, Maria Teresa Lupo Stanghellini, Fabio Giglio, Simona Piemontese, Magda Marcatti

J Clin Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corneal and Epidermal Nerve Quantification in Chemotherapy Induced Peripheral Neuropathy.
Nilo Riva, Filippo Bonelli, Romina Mayra Lasagni Vitar, Marco Barbariga, Philippe Fonteyne, Magda Marcatti

Front Med (Lausanne)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Not only a time-saving approach: Is it the time of subcutaneous formulation for daratumumab administration?
Gianluca Perego, Giorgia Longobardo, Cinzia Veneziano, Francesca Farina, Magda Marcatti

J Oncol Pharm Pract· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant.
Raffaella Greco, Francesca Lorentino, Serena Albanese, Maria Teresa Lupo Stanghellini, Fabio Giglio, Magda Marcatti

Transplant Cell Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial.
Lorenzo Lazzari, Annalisa Ruggeri, Maria Teresa Lupo Stanghellini, Sara Mastaglio, Carlo Messina, Magda Marcatti

Front Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients.
Fabio Serpenti, Francesca Lorentino, Sarah Marktel, Raffaella Milani, Carlo Messina, Magda Marcatti

Front Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies.
Oronza A Botrugno, Silvia Bianchessi, Desirée Zambroni, Michela Frenquelli, Daniela Belloni, Magda Marcatti

Haematologica· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse.
Vittorio Montefusco, Alessandro Corso, Monica Galli, Ilaria Ardoino, Sara Pezzatti, Magda Marcatti

Br J Haematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clofarabine and Treosulfan as Conditioning for Matched Related and Unrelated Hematopoietic Stem Cell Transplantation: Results from the Clo3o Phase II Trial.
Jacopo Peccatori, Sara Mastaglio, Fabio Giglio, Raffaella Greco, Roberto Crocchiolo, Magda Marcatti

Biol Blood Marrow Transplant· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis